David A. Siegel Neuronetics, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 50,600 shares of STIM stock, worth $88,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,600

Previous 51,000 0.78%

Holding current value

$88,550

Previous $147,000 63.27%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.68 - $4.8 $1,072 - $1,920	-400 Reduced 0.78%	50,600 $240,000
Q4 2023 Feb 14, 2024	SELL	$1.05 - $2.9 $86,730 - $239,540	-82,600 Reduced 61.83%	51,000 $147,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $2.22 $93,396 - $160,728	-72,400 Reduced 35.15%	133,600 $180,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $36,018 - $50,808	-17,400 Reduced 7.79%	206,000 $442,000
Q1 2023 May 15, 2023	SELL	$2.81 - $6.71 $21,356 - $50,996	-7,600 Reduced 3.29%	223,400 $650,000

Q4 2022 Feb 14, 2023	BUY	$3.44 - $6.87 $151,360 - $302,280	44,000 Added 23.53%	231,000 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $145,935 - $289,386	62,100 Added 49.72%	187,000 $595,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $15,465 - $27,454	-7,400 Reduced 5.59%	124,900 $401,000
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $237,708 - $378,323	-83,700 Reduced 38.75%	132,300 $401,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $514,710 - $876,470	-133,000 Reduced 38.11%	216,000 $963,000
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $1.33 Million - $3.33 Million	214,000 Added 158.52%	349,000 $2.29 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $65,975 - $112,125	6,500 Added 5.06%	135,000 $2.16 Million
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $1.36 Million - $2.73 Million	128,500 New	128,500 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $104,445 - $241,594	-21,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.82 - $5.87 $221,130 - $713,205	-121,500 Reduced 85.2%	21,100 $103,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.61 $14,382 - $26,622	10,200 Added 7.7%	142,600 $275,000
Q1 2020 May 15, 2020	BUY	$1.28 - $4.5 $139,904 - $491,850	109,300 Added 473.16%	132,400 $250,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $93,093 - $212,982	23,100 New	23,100 $104,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account